CN106754652B - IPS cell differentiation at ectoderm progenitor cells serum-free induced medium and abductive approach - Google Patents
IPS cell differentiation at ectoderm progenitor cells serum-free induced medium and abductive approach Download PDFInfo
- Publication number
- CN106754652B CN106754652B CN201710128088.9A CN201710128088A CN106754652B CN 106754652 B CN106754652 B CN 106754652B CN 201710128088 A CN201710128088 A CN 201710128088A CN 106754652 B CN106754652 B CN 106754652B
- Authority
- CN
- China
- Prior art keywords
- ips cell
- progenitor cells
- serum
- medium
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a kind of iPS cell differentiations into the serum-free induced medium and abductive approach of ectoderm progenitor cells.The serum-free induced medium is by adding final concentration of 8 μM of Indomethacin in every 500ml DMEM/F12 basal medium, the glutamine of percent by volume 1%, the nonessential amino acid of percent by volume 1%, 10 μM of SB431542, the EGF of 12ng/ml, 0.1mmol/ml β mercaptoethanol, the hydrocortisone of 0.4 μ g/ml, the insulin of 60 μ g/ml, the transferrins of 100 μ g/ml, the sodium selenite of 10ng/ml, the penicillin of 0.1mg/ml and the streptomysin of 0.1mg/ml are prepared.IPS cell directional can be induced to differentiate at the serum-free induced medium and abductive approach of ectoderm progenitor cells by using above-mentioned iPS cell differentiation by ectoderm progenitor cells, to be induced to differentiate into each cell of adult for iPS, especially skin relevant cell provides technical support.
Description
Technical field
The present invention relates to field of tissue engineering technology, more particularly, to a kind of iPS cell differentiation at ectoderm progenitor cells without blood
Clear induced medium and abductive approach.
Background technique
Skin tissue engineering is research hotspot in recent years, but the relevant cell of skin belongs to terminally differentiated cells,
It is difficult to carry out cultivating amplification on a large scale in vitro.Seed cell carrys out source problem and hinders the development of organizational project, self kind
Daughter cell limited source, there are rejection, embryonic stem cells there is ethics problem again for allogeneic seed cell.Therefore from urine
The induction of urine cell is become iPS cell (inductive pluripotent stem cells) by middle collection urine cell, and iPS cell induces again to be become
The seed source that skin tissue engineering can be solved in keratinocyte, fibroblast, sweat gland cells, hair papilla cell etc. is asked
Topic.Cell is obtained from urine, it is convenient and efficient, do not have to obtain by wound, it is from a wealth of sources.
Each cell induction scheme that iPS cell is induced to differentiate into skin at present mainly has the simple cell factor to induce, altogether
Culture induction, embryoid body induction etc..However simple cell factor induced efficiency is low, there are immunogenicity, embryoids for co-culturing, inducing
There are non-directionals to induce feature for body, ultimately forms three germinal layers, cannot efficiently obtain some germinal layer.
Summary of the invention
Based on this, it is necessary to provide a kind of iPS cell differentiation into the serum-free induced medium of ectoderm progenitor cells and lure
Guiding method.
A kind of iPS cell differentiation is the serum-free induced medium of ectoderm progenitor cells, the serum-free induced medium
It is by adding final concentration of 5-10 μM of Indomethacin, percent by volume in every 500ml DMEM/F12 basal medium
1% glutamine, the nonessential amino acid of percent by volume 1%, 5-20 μM SB431542,5-18ng/ml EGF,
0.05-0.2mmol/ml β mercaptoethanol, the hydrocortisone of 0.1-1 μ g/ml, the insulin of 20-100 μ g/ml, 50-150 μ g/
The transferrins of ml, the sodium selenite of 4-15ng/ml, the penicillin of 0.05-0.1mg/ml and the strepto- of 0.05-0.1mg/ml
Element is prepared.
The serum-free induced medium is by training on the basis every 500ml DMEM/F12 in one of the embodiments,
Support base in add final concentration of 8-10 μM of Indomethacin, the glutamine of percent by volume 1%, percent by volume 1% it is non-
Essential amino acid, the EGF of 8-12 μM SB431542,10-15ng/ml, 0.08-0.12mmol/ml β mercaptoethanol, 0.1-0.5
The hydrocortisone of μ g/ml, the insulin of 50-80 μ g/ml, the transferrins of 80-120 μ g/ml, 8-12ng/ml selenous acid
The streptomysin of sodium, the penicillin of 0.08-0.1mg/ml and 0.08-0.1mg/ml is prepared.
The serum-free induced medium is by training on the basis every 500ml DMEM/F12 in one of the embodiments,
Support base in add final concentration of 8 μM of Indomethacin, the glutamine of percent by volume 1%, percent by volume 1% it is nonessential
Amino acid, the EGF of 10 μM SB431542,12ng/ml, 0.1mmol/ml β mercaptoethanol, 0.4 μ g/ml hydrocortisone,
The insulin of 60 μ g/ml, the transferrins of 100 μ g/ml, the sodium selenite of 10ng/ml, the penicillin of 0.1mg/ml and
The streptomysin of 0.1mg/ml is prepared.
A kind of iPS cell differentiation is the abductive approach of ectoderm progenitor cells, using above-mentioned serum-free induced medium to iPS
Cell carries out induction differentiation culture.
The time of the induction differentiation culture is 7-10 days in one of the embodiments,.
The iPS cell differentiation further includes luring at the abductive approach of ectoderm progenitor cells in one of the embodiments,
Before leading differentiation, the step of iPS cell is formed into unicellular embryoid body by the method for culture plate and centrifugation.
It is described in one of the embodiments, iPS cell is formed into unicellular group by the method for culture plate and centrifugation to intend
The step of idiosome is that 0.5-1 × 10 are added according to each cultivation plate hole6A iPS cell, addition EB form culture medium, then with 400-
700r/min low-speed centrifugal after five minutes, is put into 5%CO2, cultivate 30-50 hours in 37 DEG C of environment, it is quasi- to form the unicellular group
Idiosome.
The culture plate is AggreWell in one of the embodiments,TM800 culture plates.
The iPS cell differentiation further includes as follows at the abductive approach of ectoderm progenitor cells in one of the embodiments,
The step of iPS cell recovery and unicellular formation: the iPS cell of P30 is recovered, with mTeSR1 without stroma cell culture,
It is unicellular with the digestion of Accutase digestive juice, then will be described unicellular according to each cultivation plate hole in 70-80% convergence degree
0.5-1×106A iPS cell is added in the cultivation plate hole to form the unicellular embryoid body.
By using the iPS cell differentiation of above-mentioned special component and concentration at the serum-free Fiber differentiation of ectoderm progenitor cells
Base and abductive approach, iPS cell directional can be induced to differentiate into outer by each ingredient coordinated in the serum-free induced medium
Endodermal progenitor cell, to be induced to differentiate into each cell of adult for iPS, especially skin relevant cell provides technology branch
It holds.The serum-free induced medium and abductive approach do not use serum simultaneously, to efficiently avoid animal sources venereal disease
Substance bring risk, improves the safety of clinical application.And compared with traditional embryoid body culture medium containing fetal calf serum
Deng significantly improving the induction differentiation efficiency of the outside endodermal progenitor cell of iPS cell, high reliablity is applied widely.And pass through
Each constituent concentration for advanced optimizing the serum-free Fiber differentiation can obtain significantly more induction iPS cell to ectoderm
The efficiency and effect of progenitor cells differentiation.
Detailed description of the invention
Fig. 1 is the gene expression dose comparison result of the ectoderm progenitor cells of experimental group and control group, for each gene,
Left side is experimental group in figure, and right side is control group；
Fig. 2 is the expression rate comparison result of the ectoderm progenitor cell surface NCAM albumen of experimental group and control group.
Specific embodiment
To facilitate the understanding of the present invention, a more comprehensive description of the invention is given in the following sections with reference to the relevant attached drawings.In attached drawing
Give presently preferred embodiments of the present invention.But the invention can be realized in many different forms, however it is not limited to this paper institute
The embodiment of description.On the contrary, purpose of providing these embodiments is keeps the understanding to the disclosure more thorough
Comprehensively.
Unless otherwise defined, all technical and scientific terms used herein and belong to technical field of the invention
The normally understood meaning of technical staff is identical.Term as used herein in the specification of the present invention is intended merely to description tool
The purpose of the embodiment of body, it is not intended that in the limitation present invention.Term as used herein "and/or" includes one or more phases
Any and all combinations of the listed item of pass.
Present embodiments provide the serum-free induction that a kind of efficient inducing pluripotent stem cells are divided into ectoderm progenitor cells
Culture medium and abductive approach.IPS cell is first formed into unicellular group by the method for AggreWellTM800 culture plate and centrifugation
Embryoid body, experimental group unicellular embryoid body of serum-free induced medium culture, control group are to continue with embryoid body culture medium
It is cultivated.Then two groups of cell is detected by fluorescence real-time quantitative PCR and flow cytometer, comparative experiments group and
The ectoderm gene of control group and the expression of albumen.Detailed process is as follows.
One, serum-free Fiber differentiation based component and its content
1. the serum-free induced medium of experimental group
| Title | Working concentration |
| DMEM/F12 | 500ml |
| Indomethacin | 8uM |
| Glutamine | 1% |
| Nonessential amino acid | 1% |
| SB431542 | 10μM |
| EGF | 12ng/ml |
| β mercaptoethanol | 0.1mmol/l |
| Hydrocortisone | 0.4μg/ml |
| Insulin | 60μg/ml |
| Transferrins | 100μg/ml |
| Sodium selenite | 10ng/ml |
| Penicillin | 0.1mg/ml |
| Streptomysin | 0.1mg/ml |
2. the induced medium of control group
| Title | Working concentration |
| EB culture medium | 500ml |
It is understood that in other embodiments, the ingredient of the serum-free induced medium of experimental group is not limited to described in table,
As long as the serum-free induced medium satisfaction is final concentration of by adding in every 500ml DMEM/F12 basal medium
5-10 μM of Indomethacin, the glutamine of percent by volume 1%, the nonessential amino acid of percent by volume 1%, 5-20 μM
The EGF of SB431542,5-18ng/ml, 0.05-0.2mmol/ml β mercaptoethanol, 0.1-1 μ g/ml hydrocortisone, 20-
The blueness of the insulin of 100 μ g/ml, the transferrins of 50-150 μ g/ml, the sodium selenite of 4-15ng/ml, 0.05-0.1mg/ml
The streptomysin of mycin and 0.05-0.1mg/ml are prepared, as long as further meeting is by every 500ml
Final concentration of 8-10 μM of Indomethacin, the glutamine of percent by volume 1%, volume are added in DMEM/F12 basal medium
The nonessential amino acid of percentage 1%, the EGF of 8-12 μM SB431542,10-15ng/ml, 0.08-0.12mmol/ml β mercapto
Base ethyl alcohol, the hydrocortisone of 0.1-0.5 μ g/ml, the insulin of 50-80 μ g/ml, 80-120 μ g/ml transferrins, 8-
The streptomysin of the sodium selenite of 12ng/ml, the penicillin of 0.08-0.1mg/ml and 0.08-0.1mg/ml be prepared i.e.
It can.
Two, step
(1) preparation of experimental group culture medium
By 500ml basal medium DMEM/F12 be added Insulin 3 0mg, hydrocortisone 0.2mg, transferrins 50mg,
5 μ g of sodium selenite, β mercaptoethanol 0.05mmol, EGF6 μ g, 10 SB431542 μM (micromolecular inhibitor), Indomethacin 8uM,
Nonessential amino acid 5ml (purchase from: hundred Aurion of Beijing wins Science and Technology Ltd., product number: BL1266), glutamine 5ml,
Penicillin 50mg and streptomysin 50mg.
(2) control group culture medium
(main component: embryoid body (EB) basis of formation culture medium, embryoid body (EB) form Special tire ox blood to EB culture medium
Clearly, glutamine, dual anti-, nonessential amino acid, 2 mercapto ethanol, producer: Sai Ye Biotechnology Co., Ltd, product number:
MUXES-90051)。
(3) recovery cell: the iPS cell (source Chinese Academy of Sciences Guangzhou Institute of Biomedicine and Health) of P30 is selected
It recovers, is unicellular, meter with the digestion of Accutase digestive juice when 80% convergence degree with mTeSR1 without stroma cell culture
Number.
(4) formation of unicellular embryoid body: each AggreWell is pressedTM1 × 10 is added in 800 cultivation plate holes6It is a thin
Born of the same parents, are added EB and form culture medium, operation manual are used by product, by AggreWellTM800 culture plates with 700r/min low speed from
After heart 5min, it is put into 5%CO2, cultivate in 37 DEG C of incubators, form unicellular embryoid body after cultivating 48h.
(5) induction differentiation: being transferred in 24 orifice plate of low adsorption of unicellular embryoid body will be formed, 24 orifice plates are divided into two
Liquid is changed in group, experimental group and control group, every group of 12 holes every other day, cultivates to after 7 days, the gene expression dose of external endodermal progenitor cell
It is detected with surface protein expression.
(6) identification of ectoderm progenitor cells:
It uses the digestive juice containing 0.25% trypsase and 0.02%EDTANa2 to handle 1-3 minutes in cell, makes cell detachment
Culture substrate simultaneously becomes unicellular, and the culture medium containing 10% fetal calf serum is added and carries out neutralization digestion, and 1200rpm is centrifuged 5 minutes,
With cold PBS buffer solution rinse cell, cell precipitation is collected in 1.5ml EP pipe, cell total rna extracts kit is used
(RneasyMiniKit, QIAGEN74104) by its operation instruction lytic cell and extracts intracellular total serum IgE, utilizes ultraviolet point
After light photometric determination RNA concentration and purity, using reverse transcription reagent box (ReverTraAceqPCRRTMasterMix,
It TOYOBOFSQ-201 is) cDNA by 1 μ g total serum IgE reverse transcription.CDNA, primer are reacted into premix reagent with qPCR
(THUNDERBIRDSYBRqPCRMix, TOYOBOQPS-201) mixing, it is real-time by the opticon2 fluorescence of Bio-Rad company
Quantitative PCR apparatus expands target gene, using people GAPDH gene expression amount as reference.Each sample reaction is independent to repeat three
It is secondary to eliminate systematic error.
Inducing cell mrna expression is identified in aforementioned manners, identifies ectoderm progenitor cells differentiation gene
The expression of GBX2, HoxA1, SOX1 and ZIC1, as a result as shown in Figure 1.
(7) flow cytometry identifies cell surface marker Protein Detection:
Cell surface marker Protein Detection is identified using flow cytometry, concrete operations are as follows:
Take 1 × 106A cell uses the digestive juice containing 0.25% trypsase and 0.02%EDTANa2 to handle 1-3 minutes, makes
Cell detachment culture substrate simultaneously becomes unicellular, and the culture medium containing 10% fetal calf serum is added and carries out neutralization digestion,
1200rpm is centrifuged 5 minutes, and with cold PBS buffer solution rinse cell, cell is resuspended in 100 μ l PBS buffer solution after being centrifuged again
In, the NCAM antibody (fluorescent component: FITC, producer: green skies Biotechnology Co., Ltd, product for carrying fluorescent marker is added
Number: A0562) and mix, 4 DEG C are protected from light incubation 45 minutes.After antibody incubation by cell with twice of cold PBS buffer solution rinse to remove
Unbonded antibody is removed, then cell is resuspended in 400 μ l PBS buffer solution, using stream type cell analyzer to cell surface
The expression rate of NCAM albumen is detected.As a result as shown in Figure 2.
Three, result
The result shows that the high expression rate of ectoderm progenitor cells differentiation gene GBX2, HoxA1, SOX1 and ZIC1 illustrate iPS
The directed differentiation of cell, the efficiency using the outside endodermal progenitor cell differentiation of the cell of experimental group are significantly higher than control group, illustrate benefit
Efficiently ectoderm progenitor cells can be divided by inducing pluripotent stem cells with the method for the present embodiment.Whole process is not used simultaneously
To serum, animal derived pathogen bring risk is effectively avoided, the safety of clinical application is improved.
Each technical characteristic of embodiment described above can be combined arbitrarily, for simplicity of description, not to above-mentioned reality
It applies all possible combination of each technical characteristic in example to be all described, as long as however, the combination of these technical characteristics is not deposited
In contradiction, all should be considered as described in this specification.
The embodiments described above only express several embodiments of the present invention, and the description thereof is more specific and detailed, but simultaneously
It cannot therefore be construed as limiting the scope of the patent.It should be pointed out that coming for those of ordinary skill in the art
It says, without departing from the inventive concept of the premise, various modifications and improvements can be made, these belong to protection of the invention
Range.Therefore, the scope of protection of the patent of the invention shall be subject to the appended claims.
Claims (9)
1. the serum-free induced medium that a kind of iPS cell differentiation is ectoderm progenitor cells, which is characterized in that the serum-free lures
Leading culture medium is by adding final concentration of 5-10 μM of Indomethacin, volume in every 500ml DMEM/F12 basal medium
The glutamine of percentage 1%, the nonessential amino acid of percent by volume 1%, 5-20 μM SB431542,5-18ng/ml
EGF, 0.05-0.2mmol/ml β mercaptoethanol, the hydrocortisone of 0.1-1 μ g/ml, 20-100 μ g/ml insulin, 50-
Transferrins, the sodium selenite of 4-15ng/ml, the penicillin of 0.05-0.1mg/ml and the 0.05-0.1mg/ml of 150 μ g/ml
Streptomysin be prepared.
2. iPS cell differentiation as described in claim 1 is the serum-free induced medium of ectoderm progenitor cells, feature exists
In the serum-free induced medium is by adding final concentration of 8-10 μM in every 500ml DMEM/F12 basal medium
Indomethacin, the glutamine of percent by volume 1%, the nonessential amino acid of percent by volume 1%, 8-12 μM
The EGF of SB431542,10-15ng/ml, 0.08-0.12mmol/ml β mercaptoethanol, 0.1-0.5 μ g/ml hydrocortisone,
The insulin of 50-80 μ g/ml, the transferrins of 80-120 μ g/ml, the sodium selenite of 8-12ng/ml, 0.08-0.1mg/ml
The streptomysin of penicillin and 0.08-0.1mg/ml are prepared.
3. iPS cell differentiation as claimed in claim 2 is the serum-free induced medium of ectoderm progenitor cells, feature exists
In the serum-free induced medium is by adding final concentration of 8 μM in every 500ml DMEM/F12 basal medium
Indomethacin, the glutamine of percent by volume 1%, the nonessential amino acid of percent by volume 1%, 10 μM of SB431542,
EGF, 0.1mmol/ml β mercaptoethanol, the hydrocortisone of 0.4 μ g/ml, the insulin of 60 μ g/ml, the 100 μ g/ of 12ng/ml
The transferrins of ml, the sodium selenite of 10ng/ml, the penicillin of 0.1mg/ml and 0.1mg/ml streptomysin be prepared.
4. the abductive approach that a kind of iPS cell differentiation is ectoderm progenitor cells, which is characterized in that using as in claim 1-3
Described in any item serum-free induced mediums carry out induction differentiation culture to iPS cell.
5. the abductive approach that iPS cell differentiation as claimed in claim 4 is ectoderm progenitor cells, which is characterized in that described to lure
The time for leading differentiation culture is 7-10 days.
6. iPS cell differentiation as claimed in claim 5 is at the abductive approach of ectoderm progenitor cells, which is characterized in that further include
Before induction differentiation, the step of iPS cell is formed into unicellular embryoid body by the method for culture plate and centrifugation.
7. iPS cell differentiation as claimed in claim 6 is at the abductive approach of ectoderm progenitor cells, which is characterized in that described to incite somebody to action
The step of iPS cell forms unicellular embryoid body by the method for culture plate and centrifugation is added according to each cultivation plate hole
0.5-1×106A iPS cell, addition EB form culture medium, then to be put into after 400-700r/min low-speed centrifugal 4-10 minutes
5%CO2, cultivate 30-50 hours in 37 DEG C of environment, form the unicellular embryoid body.
8. iPS cell differentiation as claimed in claim 7 is at the abductive approach of ectoderm progenitor cells, which is characterized in that the training
Supporting plate is AggreWellTM800 culture plates.
9. iPS cell differentiation as described in any one of claim 6-8 exists at the abductive approach of ectoderm progenitor cells, feature
In further including the steps that following iPS cell recovery and unicellular formation: the iPS cell of P30 is recovered, with mTeSR1 without
Stroma cell culture is unicellular with the digestion of Accutase digestive juice, then unicellular press described in 70-80% convergence degree
According to each cultivation plate hole 1 × 106A iPS cell is added in the cultivation plate hole to form the unicellular embryoid body.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710128088.9A CN106754652B (en) | 2017-03-06 | 2017-03-06 | IPS cell differentiation at ectoderm progenitor cells serum-free induced medium and abductive approach |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710128088.9A CN106754652B (en) | 2017-03-06 | 2017-03-06 | IPS cell differentiation at ectoderm progenitor cells serum-free induced medium and abductive approach |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106754652A CN106754652A (en) | 2017-05-31 |
| CN106754652B true CN106754652B (en) | 2019-04-02 |
Family
ID=58961816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710128088.9A Active CN106754652B (en) | 2017-03-06 | 2017-03-06 | IPS cell differentiation at ectoderm progenitor cells serum-free induced medium and abductive approach |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106754652B (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1416345A (en) * | 2000-03-09 | 2003-05-07 | 威斯康星校友研究基金会 | Serum free cultivation of primate embryonic stem cells |
| CN101490243A (en) * | 2006-07-12 | 2009-07-22 | 谢菲尔德大学 | Cell growth medium |
| CN102186969A (en) * | 2008-06-25 | 2011-09-14 | 国家健康与医学研究院 | Methods for preparing human skin substitutes from human pluripotent stem cells |
| CN103333920A (en) * | 2013-06-18 | 2013-10-02 | 西北农林科技大学 | Culture medium for establishing pig iPS cell line and culture method thereof |
| CN103525750A (en) * | 2013-09-10 | 2014-01-22 | 中国科学院广州生物医药与健康研究院 | Culture medium and application thereof |
| CN105886457A (en) * | 2016-05-16 | 2016-08-24 | 中国人民解放军军事医学科学院野战输血研究所 | Method for inducing stem cell differentiation to form epiblast progenitor cell |
| CN106434535A (en) * | 2015-08-11 | 2017-02-22 | 中国科学院广州生物医药与健康研究院 | Method for controlling stem cell differentiation |
-
2017
- 2017-03-06 CN CN201710128088.9A patent/CN106754652B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1416345A (en) * | 2000-03-09 | 2003-05-07 | 威斯康星校友研究基金会 | Serum free cultivation of primate embryonic stem cells |
| CN101490243A (en) * | 2006-07-12 | 2009-07-22 | 谢菲尔德大学 | Cell growth medium |
| CN102186969A (en) * | 2008-06-25 | 2011-09-14 | 国家健康与医学研究院 | Methods for preparing human skin substitutes from human pluripotent stem cells |
| CN103333920A (en) * | 2013-06-18 | 2013-10-02 | 西北农林科技大学 | Culture medium for establishing pig iPS cell line and culture method thereof |
| CN103525750A (en) * | 2013-09-10 | 2014-01-22 | 中国科学院广州生物医药与健康研究院 | Culture medium and application thereof |
| CN106434535A (en) * | 2015-08-11 | 2017-02-22 | 中国科学院广州生物医药与健康研究院 | Method for controlling stem cell differentiation |
| CN105886457A (en) * | 2016-05-16 | 2016-08-24 | 中国人民解放军军事医学科学院野战输血研究所 | Method for inducing stem cell differentiation to form epiblast progenitor cell |
Non-Patent Citations (5)
| Title |
|---|
| 体外诱导实现猪的ips细胞向神经干细胞分化;张鼎等;《鸡西大学学报》;20150630;第15卷(第6期);59-62 |
| 单细胞聚团拟胚体形成诱导人多能干细胞造血分化的技术优化;徐鉴城等;《中国医药导报》;20150630;第12卷(第16期);10 |
| 维生素C体外诱导多能干细胞向心肌细胞的分化;杨梁等;《中国组织工程研究与临床康复》;20110604;第15卷(第23期);4229-4232 |
| 胚胎干细胞向体表外胚层及角膜上皮细胞分化过程中信号通路的调节;侯璐璐等;《中国药理学与毒理学杂志》;20170228;第31卷(第2期);195-201 |
| 诱导多功能干细胞研究进展及其在烧伤领域的临床应用;谭加等;《中华损伤与修复杂志》;20121231;第7卷(第5期);520-522 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106754652A (en) | 2017-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107217028B (en) | Tissue engineering skin containing accessory and preparation method thereof | |
| Okada et al. | Hydrogen sulphide increases hepatic differentiation of human tooth pulp stem cells compared with human bone marrow stem cells | |
| CN104232574A (en) | Method for in-vitro directional differentiation inducing of mesenchymal stem cell towards melanocyte | |
| CN101821383A (en) | A kind of primary mesenchymal stem cells and application thereof that is used for substratum, method and the acquisition of the external mass-producing cultivation of human adult primary mesenchymal stem cells | |
| CN106350521A (en) | Preparation method of ALS (Amyotrophic Lateral Sclerosis) patient specific motor neuron | |
| CN104774808A (en) | Method for inducible differentiation of umbilical cord mesenchymal stem cells into gamma-aminobutyric acid-ergic neuron | |
| WO2017097007A1 (en) | Differentiation medium and use thereof in preparation of neural stem cells | |
| CN106867961A (en) | A kind of induced multi-potent stem cell forms mesoblastemic inducing culture and abductive approach | |
| CN115011553A (en) | Preparation method and application of stem neural crest-derived bone marrow mesenchymal stem cells | |
| CN106119191A (en) | A kind of placental villi plate mescenchymal stem cell and clinicization preparation method | |
| CN111344392B (en) | Cell induction method | |
| JP5636174B2 (en) | Method for producing mesenchymal cells or chondrocytes and method for suppressing carcinogenicity | |
| CN104789531A (en) | Method for inducing umbilical cord mesenchymal stem cells to be differentiated into dopaminergic neurons | |
| CN100540659C (en) | A kind of method and special culture media thereof of cultivating mouse embryo stem cell | |
| CN104745529B (en) | Leptin is divided into purposes and its application in hematopoietic stem/progenitor in inducing embryo stem cell | |
| CN106754652B (en) | IPS cell differentiation at ectoderm progenitor cells serum-free induced medium and abductive approach | |
| US20050095708A1 (en) | Characterization and isolation of subsets of human embryonic stem cells (HES) and cells associated or derived therefrom | |
| CN106318979A (en) | Method for inducing transdifferentiation of mesenchymal stem cells into skin stem cells | |
| CN106754653B (en) | IPS cell differentiation at entoderm progenitor cells serum-free induced medium and abductive approach | |
| CN103361310A (en) | Culture medium, kit and application thereof | |
| WO2003040355A1 (en) | Characterization and isolation of subsets of human embryonic stem cells (hes) and cells associated or derived therefrom | |
| CN113528576A (en) | Recurrent grapevine patient specific induced pluripotent stem cell line containing NLRP7 pure and mutant and construction method thereof | |
| CN110592007B (en) | Mesenchymal stem cell and preparation method and application thereof | |
| KR101738715B1 (en) | Method for derivation of pluripotent stem cells using plant stem cells or callus extracts, and pluripotent stem cells produced using the same | |
| Daneshvar et al. | Induction of pluripotency in human umbilical cord mesenchymal stem cells in feeder layer-free condition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information | ||
| CB02 | Change of applicant information |
Address after: 510730, No. 10 (6) building fifth, Yongsheng Road, Yonghe Economic Zone, Guangzhou economic and Technological Development Zone, Guangzhou, Guangdong Applicant after: Guangzhou rainbow pharmaceutical Polytron Technologies Inc Address before: 510730, No. 10 (6) building fifth, Yongsheng Road, Yonghe Economic Zone, Guangzhou economic and Technological Development Zone, Guangzhou, Guangdong Applicant before: Guangzhou Rainhome Pharmaceutical Co., Ltd. |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant |